Home
About
Overview
Sharing Data
ORCID
Help
History (57)
Thymoma and thymic carcinomas.
Chapman, Arlene
Kenton, Kimberly
Bringing Onco-Innovation to Europe's Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised Medicine.
Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy.
See All 57 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy.
Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy. Biochem Pharmacol. 2025 06; 236:116850.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Breast Neoplasms
Female
Humans
Molecular Targeted Therapy
Phosphatidylinositol 3-Kinases
Protein Kinase Inhibitors
Proto-Oncogene Proteins c-akt
Signal Transduction
TOR Serine-Threonine Kinases
authors with profiles
Ravi Salgia